Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-02-06 23:16 | 2014-02-05 | MELA | STRATA Skin Sciences, Inc. | DIMUN ANTHONY J | Director | BUY | $0.74 | 13,513 | $10,000 | 13,513 |
| 2014-02-06 22:58 | 2014-02-05 | MELA | STRATA Skin Sciences, Inc. | Swintek Kathryn B | Director | BUY | $0.74 | 13,513 | $10,000 | 33,513 |
| 2014-02-06 20:53 | 2014-02-05 | MELA | STRATA Skin Sciences, Inc. | Crane Rosemary A | Director, Officer | BUY | $0.74 | 67,570 | $50,002 | 67,570 |
| 2014-02-06 20:29 | 2014-02-05 | MELA | STRATA Skin Sciences, Inc. | Coradini Robert | Director, Officer | BUY | $0.74 | 67,567 | $50,000 | 139,024 |
| 2014-02-06 02:32 | 2014-02-03 | SYK | STRYKER CORP | Benscoter Steven P | Officer | OPT+S | $76.87 | 12,675 | $974,320 | 8,739 |
| 2014-02-06 01:06 | 2014-01-22 | CTSO | Cytosorbents Corp | Capponi Vincent | Officer | OPT+S | $0.27 | 100,000 | $27,000 | 8,150,586 |
| 2014-02-06 01:03 | 2014-02-03 | PODD | INSULET CORP | LIAMOS CHARLES T | Director | OPT+S | $42.93 | 11,037 | $473,849 | 77,316 |
| 2014-02-06 01:01 | 2014-02-03 | PODD | INSULET CORP | DeSisto Duane | Director, Officer | OPT+S | $42.95 | 20,000 | $859,090 | 184,293 |
| 2014-02-06 00:58 | 2014-02-03 | PODD | INSULET CORP | Devlin Peter | Officer | OPT+S | $42.82 | 30,000 | $1,284,639 | 63,081 |
| 2014-02-05 00:48 | 2014-02-04 | SYK | STRYKER CORP | Scannell Timothy J | Officer | OPT+S | $76.84 | 7,500 | $576,284 | 29,454 |
| 2014-02-04 22:37 | 2014-02-03 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $37.63 | 7,600 | $285,996 | 130,307 |
| 2014-02-05 00:20 | 2014-02-03 | BSX | BOSTON SCIENTIFIC CORP | MARIO ERNEST | Director | SELL | $13.19 | 10,000 | $131,884 | 364,959 |
| 2014-01-30 03:04 | 2014-01-27 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $36.67 | 10,000 | $366,656 | 124,297 |
| 2014-01-29 01:36 | 2014-01-27 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | OPT+S | $38.37 | 3,206 | $123,022 | 16,905 |
| 2014-01-29 00:59 | 2014-01-24 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director, Officer | SELL | $8.20 | 200 | $1,640 | 429,837 |
| 2014-01-28 03:57 | 2014-01-23 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $36.49 | 14,000 | $510,810 | 195,865 |
| 2014-01-25 00:39 | 2013-03-13 | ATRC | AtriCure, Inc. | LUX ANDREW L | Officer | BUY | $8.39 | 1,000 | $8,390 | 20,229 |
| 2014-01-25 00:20 | 2014-01-22 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director, Officer | SELL | $8.24 | 3,900 | $32,124 | 430,037 |
| 2014-01-23 05:13 | 2014-01-21 | DXCM | DEXCOM INC | ROPER JESS | Officer | OPT+S | $37.38 | 8,000 | $299,067 | 65,808 |
| 2014-01-22 01:27 | 2014-01-17 | MDXG | MIMEDX GROUP, INC. | PETIT PARKER H | Director, Officer, 10% owner | OPT+S | $8.28 | 150,000 | $1,242,000 | 925,000 |
| 2014-01-22 00:12 | 2014-01-16 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director | OPT+S | $49.59 | 8,037 | $398,588 | 1,151,166 |
| 2014-01-18 00:22 | 2014-01-15 | BSX | BOSTON SCIENTIFIC CORP | Phalen Michael P. | Officer | OPT+S | $13.19 | 13,500 | $178,100 | 83,735 |
| 2014-01-17 23:15 | 2014-01-15 | BONE | Xtant Medical Holdings, Inc. | COOK GUY S | 10% owner | BUY | $0.64 | 160,000 | $102,816 | 4,760,049 |
| 2014-01-18 03:23 | 2014-01-15 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | OPT+S | $36.86 | 35,000 | $1,290,083 | 722,889 |
| 2014-01-17 00:50 | 2014-01-15 | GMED | GLOBUS MEDICAL INC | Demski David M | Director, Officer | SELL | $20.51 | 96,813 | $1,985,635 | 381,365 |
| 2014-01-17 00:13 | 2014-01-14 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director | OPT+S | $49.50 | 10,600 | $524,700 | 1,151,166 |
| 2014-01-16 03:45 | 2014-01-13 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $37.37 | 10,000 | $373,696 | 124,297 |
| 2014-01-14 21:56 | 2014-01-10 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | OPT+S | $41.80 | 4,000 | $167,186 | 16,905 |
| 2014-01-15 00:15 | 2014-01-10 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director | OPT+S | $49.51 | 99,032 | $4,902,985 | 1,151,166 |
| 2014-01-15 02:11 | 2014-01-10 | CYTX | PLUS THERAPEUTICS, INC. | CALHOUN CHRISTOPHER J | Director, Officer | SELL | $15.19 | 29,145 | $442,815 | 118,125 |
| 2014-01-14 05:11 | 2014-01-09 | RMD | RESMED INC | FARRELL PETER C | Director | OPT+S | $48.00 | 25,000 | $1,200,000 | 489,876 |
| 2014-01-11 00:14 | 2014-01-08 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director | OPT+S | $49.58 | 114,431 | $5,673,111 | 1,151,166 |
| 2014-01-11 03:02 | 2014-01-08 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | OPT+S | $35.36 | 16,000 | $565,725 | 144,853 |
| 2014-01-08 19:49 | 2014-01-07 | BONE | Xtant Medical Holdings, Inc. | COOK GUY S | 10% owner | SELL | $0.53 | 273,300 | $144,849 | 4,600,049 |
| 2014-01-09 00:04 | 2014-01-06 | BSX | BOSTON SCIENTIFIC CORP | MARIO ERNEST | Director | SELL | $12.50 | 10,000 | $125,000 | 374,959 |
| 2014-01-07 19:47 | 2014-01-06 | MMM | 3M CO | Little Frank R Jr. | Officer | SELL | $137.87 | 240 | $33,089 | 247 |
| 2014-01-07 19:25 | 2014-01-03 | MMM | 3M CO | Holmes Christopher D | Officer | SELL | $138.37 | 767 | $106,130 | 5,112 |
| 2014-01-07 19:36 | 2014-01-03 | MMM | 3M CO | Shin Hak Cheol | Officer | SELL | $138.37 | 1,870 | $258,752 | 46,841 |
| 2014-01-06 21:51 | 2014-01-02 | VYCO | VYCOR MEDICAL INC | FOUNTAINHEAD CAPITAL MANAGEMENT LTD | 10% owner | BUY | $1.80 | 792,523 | $1,426,541 | 4,337,720 |
| 2014-01-03 20:11 | 2014-01-02 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $41.58 | 7,600 | $316,029 | 130,307 |
| 2014-01-04 00:45 | 2014-01-02 | PODD | INSULET CORP | DeSisto Duane | Director, Officer | OPT+S | $36.07 | 20,000 | $721,374 | 184,293 |
| 2014-01-04 00:43 | 2014-01-02 | PODD | INSULET CORP | LIAMOS CHARLES T | Director, Officer | OPT+S | $36.02 | 86,000 | $3,097,634 | 77,316 |
| 2014-01-03 00:40 | 2013-12-31 | GMED | GLOBUS MEDICAL INC | Demski David M | Director, Officer | SELL | $20.25 | 3,187 | $64,537 | 478,178 |
| 2013-12-31 21:13 | 2013-12-27 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $75.00 | 21,000 | $1,574,918 | 11,259,682 |
| 2013-12-30 18:23 | 2013-12-26 | BONE | Xtant Medical Holdings, Inc. | COOK GUY S | 10% owner | SELL | $0.53 | 64,380 | $34,179 | 4,873,349 |
| 2013-12-31 00:19 | 2013-12-26 | BSX | BOSTON SCIENTIFIC CORP | MARIO ERNEST | Director | SELL | $12.06 | 10,000 | $120,600 | 384,959 |
| 2013-12-26 17:04 | 2013-12-24 | BONE | Xtant Medical Holdings, Inc. | COOK GUY S | 10% owner | SELL | $0.44 | 300,000 | $132,000 | 1,800,000 |
| 2013-12-27 03:46 | 2013-12-23 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $75.08 | 21,000 | $1,576,665 | 11,280,682 |
| 2013-12-26 18:00 | 2013-12-24 | ICUI | ICU MEDICAL INC/DE | RIGGS STEVEN | Officer | SELL | $65.00 | 7,000 | $455,000 | 7,142 |
| 2013-12-24 01:50 | 2013-12-23 | ICUI | ICU MEDICAL INC/DE | RIGGS STEVEN | Officer | SELL | $64.07 | 9,089 | $582,333 | 7,142 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.